Characterization of HCoV-229E fusion core: Implications for structure basis of coronavirus membrane fusion

Biochemical and Biophysical Research Communications

Volumn 345, Issue 3, 2006, Pages 1108-1115

  Liu, Cheng ^a,b   Feng, Youjun ^b,c   Gao, Feng ^a,b   Zhang, Qiangmin ^b,c   Wang, Ming ^a  

^a CHINA AGRICULTURAL UNIVERSITY   (China)

^b INSTITUTE OF MICROBIOLOGY   (China)

^c UNIVERSITY OF CHINESE ACADEMY OF SCIENCES   (China)

Author keywords

Fusion core; Heptad repeat regions; Human coronavirus 229E; Type I membrane fusion; Virus fusion

Indexed keywords

CORE PROTEIN; HETERODIMER; HYBRID PROTEIN; MEMBRANE PROTEIN; POLYPEPTIDE; PROTEIN SPIKE; UNCLASSIFIED DRUG; VIRUS FUSION PROTEIN;

ALPHA HELIX; ARTICLE; CONTROLLED STUDY; CORONAVIRUS; CROSS LINKING; FEASIBILITY STUDY; GEL FILTRATION; IN VITRO STUDY; MEMBRANE FUSION; MEMBRANE STRUCTURE; NONHUMAN; PRIORITY JOURNAL; PROKARYOTE; PROTEIN SECONDARY STRUCTURE; SOLUBILITY; VIRUS INFECTION;

AMINO ACID SEQUENCE; CORONAVIRUS 229E, HUMAN; CROSS-LINKING REAGENTS; DIMERIZATION; GLUTATHIONE TRANSFERASE; HUMANS; MEMBRANE FUSION; MOLECULAR SEQUENCE DATA; PHYLOGENY; PROTEIN CONFORMATION; PROTEIN STRUCTURE, SECONDARY; RECOMBINANT FUSION PROTEINS; SEQUENCE HOMOLOGY, AMINO ACID; VIRAL CORE PROTEINS; VIRAL FUSION PROTEINS;

CORONAVIRUS; HUMAN CORONAVIRUS 229E; PROKARYOTA;

EID: 33646827147     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2006.04.141     Document Type: Article

References (39)

1. Chiu S.S., Chan K.H., Chu K.W., Kwan S.W., Guan Y., Poon L.L., and Peiris J.S. Human coronavirus NL63 infection and other coronavirus infections in children hospitalized with acute respiratory disease in Hong Kong, China. Clin. Infect. Dis. 40 (2005) 1721-1729
2. Matthews J.M., Young T.F., Tucker S.P., and Mackay J.P. The core of the respiratory syncytial virus fusion protein is a trimeric coiled coil. J. Virol. 74 (2000) 5911-5920
3. Sawicki S.G., Sawicki D.L., Younker D., Meyer Y., Thiel V., Stokes H., and Siddell S.G. Functional and genetic analysis of coronavirus replicase-transcriptase proteins. PLoS Pathog. 1 (2005) e39
4. Vijgen L., Keyaerts E., Moes E., Maes P., Duson G., and Van Ranst M. Development of one-step, real-time, quantitative reverse transcriptase PCR assays for absolute quantitation of human coronaviruses OC43 and 229E. J. Clin. Microbiol. 43 (2005) 5452-5456
5. Yuan K., Yi L., Chen J., Qu X., Qing T., Rao X., Jiang P., Hu J., Xiong Z., Nie Y., Shi X., Wang W., Ling C., Yin X., Fan K., Lai L., Ding M., and Deng H. Suppression of SARS-CoV entry by peptides corresponding to heptad regions on spike glycoprotein. Biochem. Biophys. Res. Commun. 319 (2004) 746-752
6. Vabret A., Mourez T., Dina J., van der Hoek L., Gouarin S., Petitjean J., Brouard J., and Freymuth F. Human coronavirus NL63, France. Emerg. Infect. Dis. 11 (2005) 1225-1229
7. Sloots T.P., McErlean P., Speicher D.J., Arden K.E., Nissen M.D., and Mackay I.M. Evidence of human coronavirus HKU1 and human bocavirus in Australian children. J. Clin. Virol. 35 (2006) 99-102
8. Liu S., Xiao G., Chen Y., He Y., Niu J., Escalante C.R., Xiong H., Farmar J., Debnath A.K., Tien P., and Jiang S. Interaction between heptad repeat 1 and 2 regions in spike protein of SARS-associated coronavirus: implications for virus fusogenic mechanism and identification of fusion inhibitors. Lancet 363 (2004) 938-947
9. Ni L., Zhao L., Qian Y., Zhu J., Jin Z., Chen Y.W., Tien P., and Gao G.F. Design and characterization of human respiratory syncytial virus entry inhibitors. Antivir. Ther. 10 (2005) 833-840
10. Wang E., Sun X., Qian Y., Zhao L., Tien P., and Gao G.F. Both heptad repeats of human respiratory syncytial virus fusion protein are potent inhibitors of viral fusion. Biochem. Biophys. Res. Commun. 302 (2003) 469-475
11. Xu Y., Zhu J., Liu Y., Lou Z., Yuan F., Liu Y., Cole D.K., Ni L., Su N., Qin L., Li X., Bai Z., Bell J.I., Pang H., Tien P., Gao G.F., and Rao Z. Characterization of the heptad repeat regions, HR1 and HR2, and design of a fusion core structure model of the spike protein from severe acute respiratory syndrome (SARS) coronavirus. Biochemistry 43 (2004) 14064-14071
12. Ma G., Feng Y., Gao F., Wang J., Liu C., and Li Y. Biochemical and biophysical characterization of the transmissible gastroenteritis coronavirus fusion core. Biochem. Biophys. Res. Commun. 337 (2005) 1301-1307
13. Weissenhorn W., Carfi A., Lee K.H., Skehel J.J., and Wiley D.C. Crystal structure of the Ebola virus membrane fusion subunit, GP2, from the envelope glycoprotein ectodomain. Mol. Cell. 2 (1998) 605-616
14. Carr C.M., and Kim P.S. A spring-loaded mechanism for the conformational change of influenza hemagglutinin. Cell 73 (1993) 823-832
15. Chan D.C., and Kim P.S. HIV entry and its inhibition. Cell 93 (1998) 681-684
16. Ha Y., Stevens D.J., Skehel J.J., and Wiley D.C. H5 avian and H9 swine influenza virus haemagglutinin structures: possible origin of influenza subtypes. EMBO J. 21 (2002) 865-875
17. Jiang S., and Debnath A.K. Development of HIV entry inhibitors targeted to the coiled-coil regions of gp41. Biochem. Biophys. Res. Commun. 269 (2000) 641-646
18. Root M.J., Kay M.S., and Kim P.S. Protein design of an HIV-1 entry inhibitor. Science 291 (2001) 884-888
19. Starr-Spires L.D., and Collman R.G. HIV-1 entry and entry inhibitors as therapeutic agents. Clin. Lab. Med. 22 (2002) 681-701
20. Weiss C.D. HIV-1 gp41: mediator of fusion and target for inhibition. AIDS Rev. 5 (2003) 214-221
21. Eckert D.M., Malashkevich V.N., Hong L.H., Carr P.A., and Kim P.S. Inhibiting HIV-1 entry: discovery of D-peptide inhibitors that target the gp41 coiled-coil pocket. Cell 99 (1999) 103-115
22. Xu Y., Cole D.K., Lou Z., Liu Y., Qin L., Li X., Bai Z., Yuan F., Rao Z., and Gao G.F. Construct design, biophysical, and biochemical characterization of the fusion core from mouse hepatitis virus (a coronavirus) spike protein. Protein Expr. Purif. 38 (2004) 116-122
23. Yu M., Wang E., Liu Y., Cao D., Jin N., Zhang C.W., Bartlam M., Rao Z., Tien P., and Gao G.F. Six-helix bundle assembly and characterization of heptad repeat regions from the F protein of Newcastle disease virus. J. Gen. Virol. 83 (2002) 623-629
24. Egelhofer M., Brandenburg G., Martinius H., Schult-Dietrich P., Melikyan G., Kunert R., Baum C., Choi I., Alexandrov A., and von Laer D. Inhibition of human immunodeficiency virus type 1 entry in cells expressing gp41-derived peptides. J. Virol. 78 (2004) 568-575
25. Greenberg M., Cammack N., Salgo M., and Smiley L. HIV fusion and its inhibition in antiretroviral therapy. Rev. Med. Virol. 14 (2004) 321-337
26. Yuan W., Craig S., Si Z., Farzan M., and Sodroski J. CD4-induced T-20 binding to human immunodeficiency virus type 1 gp120 blocks interaction with the CXCR4 coreceptor. J. Virol. 78 (2004) 5448-5457
27. Weis W.I., Cusack S.C., Brown J.H., Daniels R.S., Skehel J.J., and Wiley D.C. The structure of a membrane fusion mutant of the influenza virus haemagglutinin. EMBO J. 9 (1990) 17-24
28. Zhao X., Singh M., Malashkevich V.N., and Kim P.S. Structural characterization of the human respiratory syncytial virus fusion protein core. Proc. Natl. Acad. Sci. USA 97 (2000) 14172-14177
29. Xu Y., Liu Y., Lou Z., Qin L., Li X., Bai Z., Pang H., Tien P., Gao G.F., and Rao Z. Structural basis for coronavirus-mediated membrane fusion. Crystal structure of mouse hepatitis virus spike protein fusion core. J. Biol. Chem. 279 (2004) 30514-30522
30. Lambert D.M., Barney S., Lambert A.L., Guthrie K., Medinas R., Davis D.E., Bucy T., Erickson J., Merutka G., and Petteway Jr. S.R. Peptides from conserved regions of paramyxovirus fusion (F) proteins are potent inhibitors of viral fusion. Proc. Natl. Acad. Sci. USA 93 (1996) 2186-2191
31. Li P.Y., Zhu J.Q., Wu B.L., Gao F., Tien P., Rao Z., and Gao G.F. Crystallization and preliminary X-ray diffraction analysis of post-fusion six-helix bundle core structure from Newcastle disease virus F protein. Acta Crystallogr. D. Biol. Crystallogr. 59 (2003) 1296-1298
32. Zhu J., Jiang X., Liu Y., Tien P., and Gao G.F. Design and characterization of viral polypeptide inhibitors targeting Newcastle disease virus fusion. J. Mol. Biol. 354 (2005) 601-613
33. Gao G.F. Filling the hole: evidence of a small molecule binding to the fusion core pocket in human respiratory syncytial virus. Expert Opin. Investig. Drugs 14 (2005) 195-197
34. Gibbons D.L., Vaney M.C., Roussel A., Vigouroux A., Reilly B., Lepault J., Kielian M., and Rey F.A. Conformational change and protein-protein interactions of the fusion protein of Semliki Forest virus. Nature 427 (2004) 320-325
35. Modis Y., Ogata S., Clements D., and Harrison S.C. Structure of the dengue virus envelope protein after membrane fusion. Nature 427 (2004) 313-319
36. Xu Y., Lou Z., Liu Y., Pang H., Tien P., Gao G.F., and Rao Z. Crystal structure of severe acute respiratory syndrome coronavirus spike protein fusion core. J. Biol. Chem. 279 (2004) 49414-49419
37. Malashkevich V.N., Chan D.C., Chutkowski C.T., and Kim P.S. Crystal structure of the simian immunodeficiency virus (SIV) gp41 core: conserved helical interactions underlie the broad inhibitory activity of gp41 peptides. Proc. Natl. Acad. Sci. USA 95 (1998) 9134-9139
38. Xu Y., Su N., Qin L., Bai Z., Gao G.F., and Rao Z. Crystallization and preliminary crystallographic analysis of the heptad-repeat complex of SARS coronavirus spike protein. Acta Crystallogr. D. Biol. Crystallogr. 60 (2004) 2377-2379
39. Singh M., Berger B., and Kim P.S. LearnCoil-VMF: computational evidence for coiled-coil-like motifs in many viral membrane-fusion proteins. J. Mol. Biol. 290 (1999) 1031-1041